Transparency – Support for Patients’ Organizations & their activities
Patients’ organizations play a key role in supporting work to improve diagnosis, treatment and care for many therapeutic areas where pharmaceutical companies may be active. This is particularly important in the field of rare diseases, where expertise is rare and where patients may often be the experts in their own or their family’s disease or condition.
In most cases, patient representative organizations rely on support from external sources, including from pharmaceutical and biotech companies.
Mereo respects the legitimate role played by patient organizations in improving health outcomes for people with rare diseases and is actively engaged in supporting efforts by this expert community.
As part of our commitment to create sustainable value to patients, shareholders and to the community, Mereo also supports transparency initiatives, including transparency in our interactions with and support for patient organizations and their activities.
In order to secure future collaboration and to increase public awareness, we are committed to making our support – both financial and in-kind – to patients’ organizations, and to their related scientific meetings, publicly available on a half-yearly basis.
- Support for Patients’ Groups 2019
- Support for Healthcare Professionals 2019
- Support for Patients’ Groups and Scientific Meetings 2018
Keep up to date with our news and developments.View our Press Releases
Keep up to date with our financial regulatory news and developments.View our regulatory news
Mereo is an innovative leader in the specialty biopharma sector with a focus on acquiring, developing and optimising the value of innovative medicines designed to address significant unmet medical needs in rare and specialty disease areas, and improve patient quality of life.View our Company Overview